Manja Veena, Lakshminrusimha Satyan, Cook Deborah J
Division of Cardiology, Department of Medicine, Veterans Affairs Medical Center, Buffalo, New York2Department of Internal Medicine, University at Buffalo, the State University of New York, Buffalo3Department of Clinical Epidemiology and Biostatistics, McM.
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Women and Children's Hospital of Buffalo and University at Buffalo, the State University of New York, Buffalo.
JAMA Pediatr. 2015 Apr;169(4):332-40. doi: 10.1001/jamapediatrics.2014.3307.
The optimal oxygen saturation (SpO2) target for extremely preterm infants is unknown.
To systematically review evidence evaluating the effect of restricted vs liberal oxygen exposure on morbidity and mortality in extremely preterm infants.
MEDLINE, PubMed, CENTRAL, and CINAHL databases from their inception to March 31, 2014, and abstracts submitted to Pediatric Academic Societies from 2000 to 2014.
All published randomized trials evaluating the effect of restricted (SpO2, 85%-89%) vs liberal (SpO2, 91%-95%) oxygen exposure in preterm infants (<28 weeks' gestation at birth).
All meta-analyses were performed using Review Manager 5.2. The Cochrane risk-of-bias tool was used to assess study quality. The summary of the findings and the level of confidence in the estimate of effect were assessed using GRADEpro. Treatment effect was analyzed using a random-effects model.
Death before hospital discharge, death or severe disability before 24 months, death before 24 months, neurodevelopmental outcomes, hearing loss, bronchopulmonary dysplasia, necrotizing enterocolitis, and severe retinopathy of prematurity.
Five trials were included in the final synthesis. These studies had a similar design with a prespecified composite outcome of death/disability at 18 to 24 months corrected for prematurity; however, this outcome has not been reported for 2 of the 5 trials. There was no difference in the outcome of death/disability before 24 months (risk ratio [RR], 1.02 [95% CI, 0.92-1.14]). Mortality before 24 months was not different (RR, 1.13 [95% CI, 0.97-1.33]); however, a significant increase in mortality before hospital discharge was found in the restricted oxygen group (RR, 1.18 [95% CI, 1.03-1.36]). The rates of bronchopulmonary dysplasia, neurodevelopmental outcomes, hearing loss, and retinopathy of prematurity were similar between the 2 groups. Necrotizing enterocolitis occurred more frequently in infants on restricted oxygen (RR, 1.24 [95% CI, 1.05-1.47]). Using the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) criteria, we found that the quality of evidence for these outcomes was moderate to low.
Although infants cared for with a liberal oxygen target had significantly lower mortality before hospital discharge than infants cared for with a restricted oxygen target, the quality of evidence for this estimate of effect is low. Necrotizing enterocolitis occurred less frequently in the liberal oxygen group. We found no significant differences in death or disability at 24 months, bronchopulmonary dysplasia, retinopathy of prematurity, neurodevelopmental outcomes, or hearing loss at 24 months.
极早产儿的最佳血氧饱和度(SpO2)目标尚不清楚。
系统评价评估限制与宽松氧暴露对极早产儿发病率和死亡率影响的证据。
MEDLINE、PubMed、CENTRAL和CINAHL数据库,从建库至2014年3月31日,以及2000年至2014年提交给儿科学术协会的摘要。
所有已发表的随机试验,评估限制(SpO2,85%-89%)与宽松(SpO2,91%-95%)氧暴露对早产儿(出生时孕周<28周)的影响。
所有荟萃分析均使用Review Manager 5.2进行。采用Cochrane偏倚风险工具评估研究质量。使用GRADEpro评估研究结果的总结和效应估计的置信水平。采用随机效应模型分析治疗效果。
出院前死亡、24个月前死亡或严重残疾、24个月前死亡、神经发育结局、听力损失、支气管肺发育不良、坏死性小肠结肠炎和严重早产儿视网膜病变。
最终合成纳入5项试验。这些研究设计相似,有一个预先设定的校正早产的18至24个月死亡/残疾复合结局;然而,5项试验中有2项未报告该结局。24个月前死亡/残疾结局无差异(风险比[RR],1.02[95%CI,0.92-1.14])。24个月前死亡率无差异(RR,1.13[95%CI,0.97-1.33]);然而,限制氧组出院前死亡率显著增加(RR,1.18[95%CI,1.03-1.36])。两组间支气管肺发育不良、神经发育结局、听力损失和早产儿视网膜病变的发生率相似。限制氧组婴儿坏死性小肠结肠炎发生更频繁(RR,1.24[95%CI,1.05-1.47])。使用推荐分级、评估、制定和评价(GRADE)标准,我们发现这些结局的证据质量为中等至低等。
尽管宽松氧目标护理的婴儿出院前死亡率显著低于限制氧目标护理的婴儿,但该效应估计的证据质量较低。宽松氧组坏死性小肠结肠炎发生频率较低。我们发现24个月时死亡或残疾、支气管肺发育不良、早产儿视网膜病变、神经发育结局或听力损失无显著差异。